Published Articles
1 article published
November 11, 2025•
1 min
OS Therapies Inc.: Pioneering the Future of Osteosarcoma Treatment
OS Therapies Inc. is on the brink of revolutionizing osteosarcoma treatment with its leading therapy, OST-HER2, achieving significant clinical and regulatory milestones. With the FDA's nod and a robust pipeline poised for commercial launch, OS Therapies is setting a new standard in a field that hasn't seen innovation in over four decades.